Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia

Background and Purpose: Thrombophilic gene alterations are a major risk factor for cerebral sinus vein thrombosis (CSVT). Up to 30% of all patients with cerebral sinus vein thrombosis (CSVT) are found to have thrombophilic defects such as prothrombin mutation (PTM) or factor V Leiden (FVL). Their re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kellermair, Lukas, Zeller, Matthias W. G., Kulyk, Caterina, Tomasits, Josef, von Oertzen, Tim J., Vosko, Milan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316430/
https://www.ncbi.nlm.nih.gov/pubmed/35888060
http://dx.doi.org/10.3390/life12070970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316430/
https://www.ncbi.nlm.nih.gov/pubmed/35888060
http://dx.doi.org/10.3390/life12070970

Ejemplares similares